NEWS
View news from our Featured Companies.
ARIANNE PHOSPHATE TO BEGIN TRADING ON THE OTCQX MARKET
DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTCQX (USA) -move will provide for greater visibility and access to the Company's shares SAGUENAY, QC, Sept. 21, 2022 /CNW/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTCQX: DRRSF) (FRANKFURT: JE9N), a...
Scientific Industries to Present at the Lytham Fall 2022 Investor Conference
BOHEMIA, NY / September 21, 2022 / Scientific Industries, Inc. (OTCQB:SCND), a life science tool provider, and a developer of digitally simplified products, announced today that it will be participating in the Lytham Partners Fall 2022 Investor Conference taking place...
S&W Seed Company to Report Fiscal Year 2022 Financial Results on Wednesday, September 28, 2022
Conference call to be conducted on Wednesday, September 28, 2022, at 11:00AM ET LONGMONT, Colo., Sept. 20, 2022 -- S&W Seed Company (Nasdaq: SANW) will report financial results for its fiscal year 2022, ended June 30, 2022, on Wednesday, September 28, 2022, before...
Shuttle Pharmaceuticals Enters into Manufacturing Agreement for Ropidoxuridine
Agreement to help advance lead clinical sensitizer drug candidate ROCKVILLE, Md., Sept. 20, 2022 -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer...
Aytu BioPharma to Report Fourth Quarter and Fiscal 2022 Financial Results on September 27, 2022
ENGLEWOOD, CO / September 20, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, with a development pipeline addressing rare, pediatric-onset disorders, will report financial results for its fourth...
Sinopharm Xingsha to Introduce ChromaDex’s Tru Niagen® at Major Mainland China Trade Show, China International Natural Health & Nutrition Expo (NHNE)
Tru Niagen® to debut at NHNE via a celebration press conference following the expo's opening ceremony LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC) today announced that Sinopharm Xingsha will debut Tru Niagen® at the major mainland China trade show, China...
PolyPid Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results for D-PLEX in the Prevention of Surgical Site Infections in Abdominal Surgery
Intends to discuss the Clinical Outcomes and Next Steps for D-PLEX100 for the Prevention of SSIs in Abdominal Surgery with the FDA and the EU Regulatory Authorities in Q1 2023 PETACH TIKVA, Israel, Sept. 19, 2022 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the...
Scientific Industries Announces Research Collaboration Incorporating DOTS™, The New Sensor Platform to Digitally Simplify Bioprocessing
DOTS Platform Is Now at Six of Fifteen Top Academic Synthetic Biology Pilot Plants in the U.S.BOHEMIA, NY and PITTSBURGH, PA / September 16, 2022 / Scientific Industries, Inc. (OTCQB:SCND), a life science tool provider announced today that its wholly-owned subsidiary,...
Mogo to Participate in the BTIG Digital Assets Conference
VANCOUVER, British Columbia - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or the "Company"), one of Canada's leading financial technology companies, today announced that Greg Feller, President, will be participating in the BTIG Digital Assets Conference on September...
Shuttle Pharmaceuticals Awarded New HDAC Inhibitor Patents for Cancer Treatment
Company awarded patents in the U.S. and Hong Kong ROCKVILLE, Md., Sept. 15, 2022 -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company, announced today that it has been awarded patents in the U.S....
ImmuCell to Participate in the Lytham Partners Fall 2022 Investor Conference
PORTLAND, Maine, Sept. 14, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
SenesTech to Participate in the Lytham Partners Fall 2022 Investor Conference
PHOENIX, Sept. 14, 2022 -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it will be participating in the Lytham Partners Fall 2022 Investor Conference taking...
Aytu BioPharma Announces Addition of Fourth Patent License for AR101/Enzastaurin
This Fourth Patent for AR101/Enzastaurin Strengthens and Broadens the Intellectual Property Portfolio Surrounding the Treatment of Inherited Vascular Disorders Including Vascular Ehlers-Danlos Syndrome (VEDS).Multiple Patent Families Filed in Key Global...
Zoomd continues on the growth path by adding Mexico-based leading magazine, El Universal, to the company’s portfolio of publishers
VANCOUVER, BC, Sept. 14, 2022 /CNW/ -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing tech (MarTech) user-acquisition and engagement platform, is pleased to announce...
Mogo to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
VANCOUVER, British Columbia - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or the "Company"), one of Canada's leading financial technology companies, today announced that Greg Feller, President, will be participating in the H.C. Wainwright 24th Annual Global Investment...
LiqTech to Participate in the 2022 Lake Street BIG6 Conference
Company files updated slide presentation including discussion on recent market activity BALLERUP, Denmark, Sept. 13, 2022 -- LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration products and...
Kiora Pharmaceuticals Appoints Melissa Tosca as Executive Vice President of Finance
Salt Lake City, Utah--(September 13, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") has appointed Melissa Tosca as Executive Vice President of Finance. Mrs. Tosca will join the executive management team and oversee finance, SEC reporting...
PolyPid Announces Presentation of Phase 2 D-PLEX Clinical Data at the European Society for Coloproctology Scientific Conference
Efficacy Data of D-PLEX100 in the Prevention of Post-Abdominal Surgery Incisional Infection will be Presented During a Podium Presentation PETACH TIKVA, Israel, Sept. 12, 2022 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company...
InfuSystem to Participate in Lake Street’s 6th Annual Best Ideas Growth (BIG6) Conference September 14, 2022
ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced...
Reviva Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference
CUPERTINO, Calif., Sept. 07, 2022 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
Modular Medical Announces Participation at Upcoming Investor Conferences
SAN DIEGO, CA / September 7, 2022 / Modular Medical Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today...
Shuttle Pharmaceuticals Announces Closing of Initial Public Offering
ROCKVILLE, Md., Sept. 6, 2022 -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT) while reducing side...
Reviva Pharmaceuticals Holdings, Inc. Announces $8.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
CUPERTINO, Calif., Sept. 06, 2022 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
PolyPid Announces Top-line Results of Phase 3 SHIELD I Trial of D-PLEX for the Prevention of Surgical Site Infections in Abdominal Surgery
SHIELD I Study did not Achieve its Primary Endpoint of Reduction in Surgical Site Infections and Mortality In an FDA Requested Pre-specified Subgroup Analysis in Subjects with Incision Lengths over 20 centimeters (n=423), D-PLEX100 + SoC Achieved a Statistically...
ChromaDex Announces Partnership with MyPharma2Go Corporation for Cross-Border Sales of Tru Niagen® and Tru Niagen® PRO into Brazil
Brazil is the first Latin American country to now welcome Tru Niagen®, with a strategy focused on reaching both consumers and Health Care Practitioners (HCPs) LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC) today announced a partnership with MyPharma2Go to conduct...